DOI QR코드

DOI QR Code

High-Level Production of High-Purity Human and Murine Recombinant Prion Proteins Functionally Compatible to In Vitro Seeding Assay

  • Hwang, Hae-Gwang (Department of Pharmacy, Sunchon National University) ;
  • Kim, Dae-Hwan (Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University) ;
  • Lee, Jeongmin (Division of Zoonoses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for Disease Control and Prevention) ;
  • Mo, Youngwon (Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University) ;
  • Lee, Se-Hoon (Department of Pharmacy, Sunchon National University) ;
  • Lee, Yongjin (Department of Pharmacy, Sunchon National University) ;
  • Hyeon, Jae Wook (Division of Zoonoses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for Disease Control and Prevention) ;
  • Lee, Sol Moe (Division of Zoonoses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for Disease Control and Prevention) ;
  • Cheon, Yong-Pil (School of Biological Sciences and Chemistry, Sungshin Women's University) ;
  • Choi, Eun-Kyoung (Ilsong Institute of Life Science, Hallym University) ;
  • Kim, Su Yeon (Division of Zoonoses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for Disease Control and Prevention) ;
  • Lee, Yeong Seon (Division of Zoonoses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for Disease Control and Prevention) ;
  • Son, Young-Jin (Department of Pharmacy, Sunchon National University) ;
  • Ryou, Chongsuk (Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University)
  • 투고 : 2018.05.29
  • 심사 : 2018.08.27
  • 발행 : 2018.10.28

초록

Recombinant (rec) prion protein (PrP) is an extremely useful resource for studying protein misfolding and subsequent protein aggregation events. Here, we report mass production of high-purity rec-polypeptide encoding the C-terminal globular domain of PrP; (90-230) for human and (89-231) for murine PrP. These proteins were expressed as His-tagged fusion proteins in E. coli cultured by a high cell-density aerobic fermentation method. RecPrPs recovered from inclusion bodies were slowly refolded under reducing conditions. Purification was performed by a sequence of metal-affinity, cation-exchange, and reverse-phase chromatography. The current procedure yielded several dozens of milligrams of recPrP per liter with >95% purity. The purified recPrPs predominantly adopted an ${\alpha}$-helix-rich conformation and were functionally sufficient as substrates to measure the seeding activity of human and animal prions. Establishment of a procedure for high-level production of high-purity recPrP supports the advancement of in vitro investigations of PrP including diagnosis for prion diseases.

키워드

참고문헌

  1. Prusiner SB. 1998. Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383. https://doi.org/10.1073/pnas.95.23.13363
  2. Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, et al. 1993. Conversion of a-helices into b-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90: 10962-10966. https://doi.org/10.1073/pnas.90.23.10962
  3. Cohen FE, Prusiner SB. 1998. Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67: 793-819. https://doi.org/10.1146/annurev.biochem.67.1.793
  4. Caughey B, Baron GS, Chesebro B, Jeffrey M. 2009. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu. Rev. Biochem. 78: 177-204. https://doi.org/10.1146/annurev.biochem.78.082907.145410
  5. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144. https://doi.org/10.1126/science.6801762
  6. Legname G, Baskakov IV, Nguyen H-OB, Riesner D, Cohen FE, DeArmond SJ, et al. 2004. Synthetic mammalian prions. Science 305: 673-676. https://doi.org/10.1126/science.1100195
  7. Wang F, Wang X, Yuan C-G, Ma J. 2010. Generating a prion with bacterially expressed recombinant prion protein. Science 327: 1132-1135. https://doi.org/10.1126/science.1183748
  8. Shin W, Lee B, Hong S, Ryou C, Kwon M. 2008. Cloning and expression of a prion protein (PrP) gene from Korean bovine (Bos taurus coreanae) and production of rabbit anti-bovine PrP antibody. Biotechnol. Lett. 30: 1705-1711. https://doi.org/10.1007/s10529-008-9768-4
  9. Kim C-L, Umetani A, Matsui T, Ishiguro N, Shinagawa M, Horiuchi M. 2004. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology 320: 40-51. https://doi.org/10.1016/j.virol.2003.10.026
  10. Korth C, Streit P, Oesch B. 1999. Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein. Methods Enzymol. 309: 106-122.
  11. White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, et al. 2003. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422: 80-83. https://doi.org/10.1038/nature01457
  12. Andrievskaia O, McRae H, Elmgren C, Huang H, Balachandran A, Nielsen K. 2006. Generation of Antibodies against bovine recombinant prion protein in various strains of mice. Clin. Vaccine Immunol. 13: 98-105. https://doi.org/10.1128/CVI.13.1.98-105.2006
  13. Stanker LH, Serban AV, Cleveland E, Hnasko R, Lemus A, Safar J, et al. 2010. Conformation-dependent high-affinity mAbs to prion proteins. J. Immunol. 185: 729-737. https://doi.org/10.4049/jimmunol.0902930
  14. Kang H-E, Weng CC, Saijo E, Saylor V, Bian J, Kim S, et al. 2012. Characterization of conformation-dependent prion protein epitopes. J. Biol. Chem. 287: 37219-37232. https://doi.org/10.1074/jbc.M112.395921
  15. Groveman BR, Dolan MA, Taubner LM, Kraus A, Wickner RB, Caughey B. 2014. Parallel in-register intermolecular $\beta$-Sheet architectures for prion-seeded prion protein (PrP) amyloids. J. Biol. Chem. 289: 24129-24142. https://doi.org/10.1074/jbc.M114.578344
  16. Damberger FF, Christen B, Perez DR, Hornemann S, Wuthrich K. 2011. Cellular prion protein conformation and function. Proc. Natl. Acad. Sci. USA 108: 17308-17313. https://doi.org/10.1073/pnas.1106325108
  17. Christen B, Hornemann S, Damberger FF, Wuthrich K. 2009. Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the b2-a2 loop is modulated by long-range sequence effects. J. Mol. Biol. 389: 833-878. https://doi.org/10.1016/j.jmb.2009.04.040
  18. Tycko R, Savtchenko R, Ostapchenko VG, Makarava N, Baskakov IV. 2010. The $\alpha$-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel $\beta$-sheet structure in PrP fibrils: Evidence from solid state NMR. Biochemistry 49: 9488-9497. https://doi.org/10.1021/bi1013134
  19. Wille H, Bian W, McDonald M, Kendall A, Colby DW, Bloch L, et al. 2009. Natural and synthetic prion structure from X-ray fiber diffraction. Proc. Natl. Acad. Sci. USA 106: 16990-16995. https://doi.org/10.1073/pnas.0909006106
  20. Lee S, Antony L, Hartmann R, Knaus KJ, Surewicz K, Surewicz WK, et al. 2010. Conformational diversity in prion protein variants influences intermolecular $\beta$-sheet formation. EMBO J. 29: 251-262. https://doi.org/10.1038/emboj.2009.333
  21. Wan W, Wille H, Stohr J, Kendall A, Bian W, McDonald M, et al. 2015. Structural studies of truncated forms of the prion protein PrP. Biophys. J. 108: 1548-1554. https://doi.org/10.1016/j.bpj.2015.01.008
  22. Colby DW, Zhang Q, Wang S, Groth D, Legname G, Riesner D, et al. 2007. Prion detection by an amyloid seeding assay. Proc. Natl. Acad. Sci. USA 104: 20914-20919. https://doi.org/10.1073/pnas.0710152105
  23. Kim S-G, Lee H-M, Ryou C. 2014. Parameters that affect macromolecular self-assembly of prion protein. Protein J. 33: 243-252. https://doi.org/10.1007/s10930-014-9556-z
  24. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, et al. 2007. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4: 645-650. https://doi.org/10.1038/nmeth1066
  25. Corsaro A, Thellung S, Russo C, Villa V, Arena S, D'Adamo MC, et al. 2002. Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein. Neurochem. Intl. 41: 55-63. https://doi.org/10.1016/S0197-0186(01)00137-1
  26. Makarava N, Baskakov IV. 2012. Purification and fibrillation of full-length recombinant PrP. Methods Mol. Biol. 849: 33-52.
  27. Makarava N, Baskakov IV. 2008. Expression and purification of full-length recombinant PrP of high purity, pp. 131-143. In Hill AF (ed.), Prion Protein Protocols, Ed. Humana Press, Totowa, NJ
  28. Zahn R, von Schroetter C, Wuthrich K. 1997. Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett. 417: 400-404. https://doi.org/10.1016/S0014-5793(97)01330-6
  29. Marbach J, Zentis P, Ellinger P, Muller H, Birkmann E. 2013. Expression and characterisation of fully posttranslationally modified cellular prion protein in Pichia pastoris. Biol. Chem. 394: 1475-1483.
  30. Sakudo A, Hamaishi M, Hosokawa-Kanai T, Tuchiya K, Nishimura T, Saeki K, et al. 2003. Absence of superoxide dismutase activity in a soluble cellular isoform of prion protein produced by baculovirus expression system. Biochem. Biophys. Res. Commun. 307: 678-683. https://doi.org/10.1016/S0006-291X(03)01239-7
  31. Faburay B, Tark D, Kanthasamy AG, Richt JA. 2014. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate. Prion. 8: 393-403. https://doi.org/10.4161/19336896.2014.983753
  32. Chu NK, Becker CFW. 2013. Recombinant expression of soluble murine prion protein for C-terminal modification. FEBS Lett. 587: 430-435. https://doi.org/10.1016/j.febslet.2012.12.026
  33. Arii Y, Oshiro S, Wada K, Fukuoka S-I. 2011. Production of a recombinant full-length prion protein in a soluble form without refolding or detergents. Biosci. Biotechnol. Biochem. 75: 1181-1183. https://doi.org/10.1271/bbb.100839
  34. Volkel D, Blankenfeldt W, Schomburg D. 1998. Large-scale production, purification and refolding of the full-length cellular prion protein from Syrian golden hamster in Escherichia coli using the glutathione S-transferase-fusion system. Eur. J. Biochem. 251: 462-471. https://doi.org/10.1046/j.1432-1327.1998.2510462.x
  35. Mehlhorn I, Groth D, Stockel J, Moffat B, Reilly D, Yansura D, et al. 1996. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35: 5528-5537. https://doi.org/10.1021/bi952965e
  36. Borchelt DR, Rogers M, Stahl N, Telling G, Prusiner SB. 1993. Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology 3: 319-329. https://doi.org/10.1093/glycob/3.4.319
  37. Gorodinsky A, Harris DA. 1995. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J. Cell Biol. 129: 619-627. https://doi.org/10.1083/jcb.129.3.619
  38. Dan H, Balachandran A, Lin M. 2009. A pair of ligation-independent Escherichia coli expression vectors for rapid addition of a polyhistidine affinity tag to the N- or C-termini of recombinant proteins. J. Biomol. Tech. 20: 241-248.
  39. Macedo B, Millen TA, Braga CACA, Gomes MPB, Ferreira PS, Kraineva J, et al. 2012. Nonspecific prion protein-nucleic acid interactions lead to different aggregates and cytotoxic species. Biochemistry 51: 5402-5413. https://doi.org/10.1021/bi300440e
  40. Vrlinic T, Debarnot D, Legeay G, Coudreuse A, El Moualij B, Zorzi W, et al. 2012. Are the interactions between recombinant prion proteins and polymeric surfaces related to the hydrophilic/hydrophobic balance? Macromol. Biosci. 12: 830-839. https://doi.org/10.1002/mabi.201100454
  41. Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C. 1999. Infectivity of scrapie prions bound to a stainless steel surface. Mol. Med. 5: 240-243. https://doi.org/10.1007/BF03402121
  42. Enari M, Flechsig E, Weissmann C. 2001. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA 98: 9295-9299. https://doi.org/10.1073/pnas.151242598
  43. Arii Y, Yamaguchi H, Fukuoka S-I. 2007. Production of a soluble recombinant prion protein fused to blue fluorescent protein without refolding or detergents in Escherichia coli cells. Biosci. Biotechnol. Biochem. 71: 2511-2514. https://doi.org/10.1271/bbb.70303
  44. Zhang F-P, Zhang J, Zhou W, Zhang B-Y, Hung T, Dong X-P. 2002. Expression of PrPC as HIS-fusion form in a baculovirus system and conversion of expressed PrP-sen to PrP-res in a cell-free system. Virus Res. 87: 145-153. https://doi.org/10.1016/S0168-1702(02)00089-8
  45. Zhang H, Stockel J, Mehlhorn I, Groth D, Baldwin MA, Prusiner SB, et al. 1997. Physical studies of conformational plasticity in a recombinant prion protein. Biochemistry. 36: 3543-3553. https://doi.org/10.1021/bi961965r
  46. Hornemann S, Korth C, Oesch B, Riek R, Wide G, Wüthrich K, et al. 1997. Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization. FEBS Lett. 413: 277-281. https://doi.org/10.1016/S0014-5793(97)00921-6
  47. Lu BY, Beck PJ, Chang JY. 2001. Oxidative folding of murine prion mPrP(23-231). Eur. J. Biochem. 268: 3767-3773. https://doi.org/10.1046/j.1432-1327.2001.02283.x
  48. Vrentas CE, Onstot S, Nicholson EM. 2012. A comparative analysis of rapid methods for purification and refolding of recombinant bovine prion protein. Protein. Expr. Purif. 82: 380-388. https://doi.org/10.1016/j.pep.2012.02.008
  49. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, et al. 1987. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61: 3688-3693.
  50. Kang H-E, Mo Y, Abd Rahim R, Lee H-M, Ryou C. 2017. Prion diagnosis: application of real-time quaking-induced conversion. BioMed. Res. Intl. 2017: 5413936
  51. Mullner S, Hoyle V. 1992. A method for directly determining intact recombinant insulin fusion proteins in crude fermentation extracts. Anal. Biochem. 202: 394-399. https://doi.org/10.1016/0003-2697(92)90124-P
  52. Clark EDB. 1998. Refolding of recombinant proteins. Curr. Opin. Biotechnol. 9: 157-163. https://doi.org/10.1016/S0958-1669(98)80109-2
  53. Cowley DJ, Mackin RB. 1997. Expression, purification and characterization of recombinant human proinsulin. FEBS Lett. 402: 124-130. https://doi.org/10.1016/S0014-5793(96)01511-6
  54. Sun J. 2012. Rapid strain evaluation using dynamic DO-stat fed-batch fermentation under scale-down conditions. Methods Mol. Biol. 834: 233-244.
  55. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S. 2005. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J. Biol. Chem. 280: 26873-26879. https://doi.org/10.1074/jbc.M503973200
  56. Deleault NR, Lucassen RW, Supattapone S. 2003. RNA molecules stimulate prion protein conversion. Nature 425: 717-720. https://doi.org/10.1038/nature01979